The United States and the Kingdom of Saudi Arabia are strengthening their strategic ties by formalising two major agreements focused on energy collaboration and critical mineral supply chains.
McLean Hospital’s Clinical and Translational Pain Research Laboratory is one of five institutions splitting a $1.67 million NIH grant - the research will examine any links between the menstrual cycle and the COVID vaccine.
The Danish Technological Institute are working on the frontier of technologies for the printed electronics industry, and explain here their areas of expertise.
The European Commission's long-term vision for the EU’s rural areas is explored here, with a focus on identifying the challenges and concerns, as well as highlighting the most promising opportunities.
The U.S. Food and Drug Administration (FDA) has given authorisation for the Pfizer/BioNTech COVID-19 booster vaccine to be administered to people aged 65 and over.
Tess Player, VP, Global Head of Expert and Influence Marketing, GSK Consumer Healthcare, discusses how low public understanding of oral health is symptomatic of the need for better everyday health education.
Open Access Government charts the science and technology policy priorities in Japan, including the areas MEXT Minister HAGIUDA Koichi has been pushing forward.
Julian Hayes, Partner, and Umar Azmeh, Associate, of BCL Solicitors LLP, examine the proposals for GDPR reform outlined in the government consultation on changes to the UK’s data protection regime.
Annabelle Neame, Director of Business Development, HCA UK Concierge Centre, looks at the rise of concierge healthcare during the COVID-19 pandemic and whether it is worth the investment.
ONS data suggests that the difference between remote learning and classroom teaching was biggest for schools in deprived areas - with some teachers only able to contact 50% of their pupils.
Maiko Kiis, Marketing Manager at Solarstone finds out if solar roofs are worth the money and tells us what we need to know about building-integrated photovoltaics (BIPV).
Here, we learn how international diagnostics group Novacyt are leading the innovation revolution in clinical diagnostics through discovery, design, and innovation.